Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.47 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.46 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cetrimonium SCHEMBL22396363 | 0.85 | TP53 (0.60) | GAATP53TSHR | |
| SCHEMBL3152156 | 0.84 | PKM (0.65) | ESR1L3MBTL1PKMMAPK1TP53 | |
| SCHEMBL16418454 | 0.81 | ESR1 (0.66) | ESR1L3MBTL1MAPTGAABCHE | |
| SCHEMBL3138707 | 0.81 | MAPT (0.77) | CA1CA2ESR1L3MBTL1MAPT | |
| SCHEMBL11052789 | 0.80 | TP53 (0.62) | CA1CA2L3MBTL1GAATP53 | |
| Bromide SCHEMBL16414995 | 0.79 | ESR1 (0.64) | ESR1L3MBTL1MAPTGAABCHE | |
| SCHEMBL3139692 | 0.78 | TDP1 (0.61) | CA1CA2ESR1L3MBTL1MAPT | |
| Bicarbonate SCHEMBL9647641 | 0.78 | CA1 (0.44) | CA1CA2ESR1L3MBTL1CHRNB4 | |
| SCHEMBL12114038 | 0.78 | ESR1 (0.48) | ESR1L3MBTL1MAPTGAABCHE | |
| Terephthalic Acid SCHEMBL30148140 | 0.77 | MEN1 (0.48) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7687546-B2 | Quaternary ammonium compound, process for producing the same, therapeutic agent for cerebrovascular disorder, and therapeutic agent for heart disease | ACTIVUS PHARMA CO., LTD. (JP) | 2010-03-30 | — | — | US | disclosed |
| US-20080269345-A1 | Quarternary Ammonium Compound, Process for Producing the Same, Therapeutic Agent for Cerebrovascular Disorder, and Therapeutic Agent for Heart Disease | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2008-10-30 | — | — | US | disclosed |
| EP-1736464-A1 | QUATERNARY AMMONIUM COMPOUND, PROCESS FOR PRODUCING THE SAME, THERAPEUTIC AGENT FOR CEREBROVASCULAR DISORDER, AND THERAPEUTIC AGENT FOR HEART DISEASE | Dainippon Ink and Chemicals, Incorporated (JP) | 2006-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269345-A1 | Quarternary Ammonium Compound, Process for Producing the Same, Therapeutic Agent for Cerebrovascular Disorder, and Therapeutic Agent for Heart Disease | HRH4, KCNH3, ARGLU1 | CA1 278/4885CA2 138/4885ESR1 2866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.